European Healthtech startup funding raised during Q1 2015.
In Q1 2015, 35 European Healthtech companies raised a combined €182M across 37 funding rounds, up 15.2% versus Q1 2014. Germany led by capital raised, and BioMed Partners was the most active investor. Data as of 23 Aug 2026.
4 exits · €273M disclosed.
| Dezima Pharma | Acquisition | Mar 2015 | €273M |
| €17M |
| EarlySense | Series D+ | Jan 2015 | €16M |
| MindMaze | Seed | Mar 2015 | €7.7M |
| Genenta Science | Series A | Jan 2015 | €5.9M |
| MediSafe | Other | Jan 2015 | €4.9M |
| Rigontec | Series A | Mar 2015 | €4.8M |
| TrialBee | Series A | Mar 2015 | €4.5M |
| Miracor Medical Systems | Series B | Jan 2015 | €4.5M |
| MySugr | Series A | Mar 2015 | €4.3M |
| Genenta Science | Series A | Mar 2015 | €3.4M |
| NBE-Therapeutics | Series A | Mar 2015 | €2.8M |
| Sekoia | Early VC | Mar 2015 | €2.7M |
